Ten evidence-based articles written for patients, physicians, and cannabis professionals. No marketing claims, no anecdote — just what the research says.
Your body already produces cannabinoids. Understanding the ECS is the first step to using cannabis medicine intentionally and safely.
The ratio of THC to CBD shapes your experience more than potency alone. Here's what the research says.
State-by-state requirements have changed. A plain-language guide to qualifying conditions, telemedicine, and what to expect.
A COA tells you everything about what's in your product. Learn to read them like a professional.
Myrcene, limonene, caryophyllene — pharmacologically active and essential to the cannabis experience.
CYP450 enzyme competition affects warfarin, antidepressants, and dozens of common medications.
The indica/sativa distinction is one of the most repeated — and most misunderstood — ideas in cannabis. Here's what the science actually says.
Starting low and going slow isn't just beginner advice — it's evidence-based. Here's what research shows about minimal effective doses.
CBD is one of the most discussed — and most misrepresented — compounds in cannabis. Here's an honest, research-based overview.
Smoking, vaping, edibles, tinctures, topicals — each delivery method has a completely different pharmacokinetic profile. What patients need to know.
Beta members get the complete Novos Leaf Journal — condition-specific protocols, research summaries, and clinical Q&A.
Join the waitlist